68
Views
57
CrossRef citations to date
0
Altmetric
Review

Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospects

&
Pages 609-633 | Published online: 25 Feb 2005

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Barbara Fingleton. (2003) Matrix metalloproteinase inhibitors for cancer therapy: the current situation and future prospects. Expert Opinion on Therapeutic Targets 7:3, pages 385-397.
Read now
Anna C Erickson & Mary Helen Barcellos-Hoff. (2003) The not-so innocent bystander: the microenvironment as a therapeutic target in cancer. Expert Opinion on Therapeutic Targets 7:1, pages 71-88.
Read now
Richard D Connell & Jean S Beebe. (2001) Patent focus on cancer chemotherapeutics. III Angiogenesis agents: October 2000 – March 2001. Expert Opinion on Therapeutic Patents 11:7, pages 1171-1203.
Read now

Articles from other publishers (54)

Qingbing Wang, Maciej Serda, Quan Li & Tao Sun. (2023) Recent Advancements on Self‐Immolative System Based on Dynamic Covalent Bonds for Delivering Heterogeneous Payloads. Advanced Healthcare Materials 12:20.
Crossref
Radu Mihail MİRİCA, Mihai IONESCU, Alexandra MIRICA, Octav GINGHINA, Razvan IOSIFESCU, Andrei- Bogdan VACARASU, Danut- Constantin CIOTARLA, Adrian ROSCA, Leon ZAGREAN & Niculae IORDACHE. (2022) Pathophysiology of metalloproteinase matrix in relation to morbid obesity and associated pathologies. The European Research Journal 8:3, pages 411-419.
Crossref
Kyoung Mee Kim & Joohee Jung. (2020) Upregulation of G Protein-Coupled Estrogen Receptor by Chrysin-Nanoparticles Inhibits Tumor Proliferation and Metastasis in Triple Negative Breast Cancer Xenograft Model. Frontiers in Endocrinology 11.
Crossref
Nicholas A. Kurniawan, Parthiv Kant Chaudhuri & Chwee Teck Lim. (2016) Mechanobiology of cell migration in the context of dynamic two-way cell–matrix interactions. Journal of Biomechanics 49:8, pages 1355-1368.
Crossref
David Jiang & Su Yin Lim. (2016) Influence of Immune Myeloid Cells on the Extracellular Matrix During Cancer Metastasis. Cancer Microenvironment 9:1, pages 45-61.
Crossref
Giuseppe Digilio, Tiziano Tuccinardi, Francesca Casalini, Claudio Cassino, David M. Dias, Carlos F.G.C. Geraldes, Valeria Catanzaro, Alessandro Maiocchi & Armando Rossello. (2014) Study of the binding interaction between fluorinated matrix metalloproteinase inhibitors and Human Serum Albumin. European Journal of Medicinal Chemistry 79, pages 13-23.
Crossref
Shane O'Sullivan, Carlos Medina, Mark Ledwidge, Marek W. Radomski & John F. Gilmer. (2014) Nitric oxide-matrix metaloproteinase-9 interactions: Biological and pharmacological significance. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1843:3, pages 603-617.
Crossref
Chi-Yu Zhang, Li Zhang, Hui-Xin Yu, Jian-Dong Bao, Zhen Sun & Rong-Rong Lu. (2013) Curcumin inhibits invasion and metastasis in K1 papillary thyroid cancer cells. Food Chemistry 139:1-4, pages 1021-1028.
Crossref
Hongmei Li, Shann S. Yu, Martina Miteva, Christopher E. Nelson, Thomas Werfel, Todd D. Giorgio & Craig L. Duvall. (2013) Matrix Metalloproteinase Responsive, Proximity-Activated Polymeric Nanoparticles for siRNA Delivery. Advanced Functional Materials 23:24, pages 3040-3052.
Crossref
Francesca Casalini, Lorenza Fugazza, Giovanna Esposito, Claudia Cabella, Chiara Brioschi, Alessia Cordaro, Luca D’Angeli, Antonietta Bartoli, Azzurra M. Filannino, Concetta V. Gringeri, Dario L. Longo, Valeria Muzio, Elisa Nuti, Elisabetta Orlandini, Gianluca Figlia, Angelo Quattrini, Lorenzo Tei, Giuseppe Digilio, Armando Rossello & Alessandro Maiocchi. (2013) Synthesis and Preliminary Evaluation in Tumor Bearing Mice of New 18 F-Labeled Arylsulfone Matrix Metalloproteinase Inhibitors as Tracers for Positron Emission Tomography . Journal of Medicinal Chemistry 56:6, pages 2676-2689.
Crossref
Concetta V. Gringeri, Valeria Menchise, Silvia Rizzitelli, Evelina Cittadino, Valeria Catanzaro, Gabriele Dati, Linda Chaabane, Giuseppe Digilio & Silvio Aime. (2012) Novel Gd(III)-based probes for MR molecular imaging of matrix metalloproteinases. Contrast Media & Molecular Imaging 7:2, pages 175-184.
Crossref
Cormac G. Gavin & Neil D. Kitchen. 2011. Youmans Neurological Surgery. Youmans Neurological Surgery 4004 4015 .
Huili LiMasahiko YonedaMasayuki TakeyamaIichiro SugitaHinako TsunekawaHiroshi YamadaDaisuke WatanabeTomoyuki MukaiMasahiro YamamuraMasayoshi IwakiMasahiro Zako. (2010) Effect of Infliximab on Tumor Necrosis Factor-Alpha-Induced Alterations in Retinal Microvascular Endothelial Cells and Retinal Pigment Epithelial Cells. Journal of Ocular Pharmacology and Therapeutics 26:6, pages 549-556.
Crossref
Yao Zhao, Peiliang Li, Weiwei Fan, Dan Chen, Yuxiang Gu, Daru Lu, Fan Zhao, Jin Hu, Chaowei Fu, Xiancheng Chen, Liangfu Zhou & Ying Mao. (2010) The rs522616 polymorphism in the matrix metalloproteinase-3 (MMP-3) gene is associated with sporadic brain arteriovenous malformation in a Chinese population. Journal of Clinical Neuroscience 17:12, pages 1568-1572.
Crossref
A K Nalla, B Gorantla, C S Gondi, S S Lakka & J S Rao. (2010) Targeting MMP-9, uPAR, and cathepsin B inhibits invasion, migration and activates apoptosis in prostate cancer cells. Cancer Gene Therapy 17:9, pages 599-613.
Crossref
Shailesh Singh, Rajesh Singh, Udai P. Singh, Shesh N. Rai, Kristian R. Novakovic, Leland W.K. Chung, Peter J. Didier, William E. Grizzle & James W. LillardJr.Jr.. (2009) Clinical and biological significance of CXCR5 expressed by prostate cancer specimens and cell lines. International Journal of Cancer 125:10, pages 2288-2295.
Crossref
Yan Li, Jing-Hui Jia, Shan Kang, Xiao-Juan Zhang, Jian Zhao, Na Wang, Rong-Miao Zhou, Dong-Lan Sun, Ya-Nan Duan & Dong-Jie Wang. (2009) The Functional Polymorphisms on Promoter Region of Matrix Metalloproteinase-12, -13 Genes May Alter the Risk of Epithelial Ovarian Carcinoma in Chinese. International Journal of Gynecological Cancer 19:1, pages 129-133.
Crossref
Randy L. Scherer, J. Oliver McIntyre & Lynn M. Matrisian. (2008) Imaging matrix metalloproteinases in cancer. Cancer and Metastasis Reviews 27:4, pages 679-690.
Crossref
Jan Burk, Dorothe Burggraf, Milan Vosko, Martin Dichgans & Gerhard F. Hamann. (2008) Protection of cerebral microvasculature after moderate hypothermia following experimental focal cerebral ischemia in mice. Brain Research 1226, pages 248-255.
Crossref
Renata Grzywa & Józef Oleksyszyn. (2008) First synthesis of α-aminoalkyl-(N-substituted)thiocarbamoyl-phosphinates: Inhibitors of aminopeptidase N (APN/CD13) with the new zinc-binding group. Bioorganic & Medicinal Chemistry Letters 18:13, pages 3734-3736.
Crossref
Ryuji Hayashi, Xiaomin Jin & Gregory R. Cook. (2007) Synthesis and evaluation of novel heterocyclic MMP inhibitors. Bioorganic & Medicinal Chemistry Letters 17:24, pages 6864-6870.
Crossref
Sateesh Kunigal, Sajani S. Lakka, Christopher S. Gondi, Norman Estes & Jasti S. Rao. (2007) Retracted : RNAi‐mediated downregulation of urokinase plasminogen activator receptor and matrix metalloprotease‐9 in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth . International Journal of Cancer 121:10, pages 2307-2316.
Crossref
Marino A. Campo, Doris Gabriel, Pavel Kucera, Robert Gurny & Norbert Lange. (2007) Polymeric Photosensitizer Prodrugs for Photodynamic Therapy. Photochemistry and Photobiology 83:4, pages 958-965.
Crossref
Maher A. Abdallah, Huda I. Abdullah, Steven Kang, Douglas D. Taylor, Steven T. Nakajima & Cicek Gercel-Taylor. (2007) Effects of the components of hormone therapy on matrix metalloproteinases in breast-cancer cells: an in vitro study. Fertility and Sterility 87:4, pages 978-981.
Crossref
Rebecca Suk Heist, Ariela L. Marshall, Geoffrey Liu, Wei Zhou, Li Su, Donna Neuberg, Thomas J. Lynch, John Wain & David C. Christiani. (2006) Matrix Metalloproteinase Polymorphisms and Survival in Stage I Non–Small Cell Lung Cancer. Clinical Cancer Research 12:18, pages 5448-5453.
Crossref
Chanhung Z Lee, Jianhua S Yao, Yong Huang, Wenwu Zhai, Weizhong Liu, B Joseph Guglielmo, Emil Lin, Guo-Yuan Yang & William L Young. (2006) Dose–Response Effect of Tetracyclines on Cerebral Matrix Metalloproteinase-9 after Vascular Endothelial Growth Factor Hyperstimulation. Journal of Cerebral Blood Flow & Metabolism 26:9, pages 1157-1164.
Crossref
J Leyden, D Murray, A Moss, M Arumuguma, E Doyle, G McEntee, C O'Keane, P Doran & P MacMathuna. (2006) Net1 and Myeov: computationally identified mediators of gastric cancer. British Journal of Cancer 94:8, pages 1204-1212.
Crossref
Tomoki Hashimoto, Melissa M Matsumoto, Jenny F Li, Michael T Lawton & William L Young. (2005) Suppression of MMP-9 by doxycycline in brain arteriovenous malformations. BMC Neurology 5:1.
Crossref
Alexandre Kaliski, Laurence Maggiorella, Keith A. Cengel, Denis Mathe, Valerie Rouffiac, Paule Opolon, Nathalie Lassau, Jean Bourhis & Eric Deutsch. (2005) Angiogenesis and tumor growth inhibition by a matrix metalloproteinase inhibitor targeting radiation-induced invasion. Molecular Cancer Therapeutics 4:11, pages 1717-1728.
Crossref
Liezhen Fu, Atsuko Ishizuya-Oka, Daniel R. Buchholz, Tosikazu Amano, Hiroki Matsuda & Yun-Bo Shi. (2005) A Causative Role of Stromelysin-3 in Extracellular Matrix Remodeling and Epithelial Apoptosis during Intestinal Metamorphosis in Xenopus laevis. Journal of Biological Chemistry 280:30, pages 27856-27865.
Crossref
Stephen C. Robinson & Lisa M. Coussens. 2005. 159 187 .
Robert J. Diaz, Alexandra Eichten, Karin E. de Visser & Lisa M. Coussens. 2005. Integration/Interaction of Oncologic Growth. Integration/Interaction of Oncologic Growth 81 126 .
Gregory R. Cook, Ethirajan Manivannan, Thane Underdahl, Viera Lukacova, Yufen Zhang & Stefan Balaz. (2004) Synthesis and evaluation of novel oxazoline MMP inhibitors. Bioorganic & Medicinal Chemistry Letters 14:19, pages 4935-4939.
Crossref
Chanhung Z. LeeBin XuTomoki HashimotoCharles E. McCullochGuo-Yuan YangWilliam L. Young. (2004) Doxycycline Suppresses Cerebral Matrix Metalloproteinase-9 and Angiogenesis Induced by Focal Hyperstimulation of Vascular Endothelial Growth Factor in a Mouse Model. Stroke 35:7, pages 1715-1719.
Crossref
Aura S. Kamiguti, Edwin S. Lee, Kathleen J. Till, Robert J. Harris, Mark A. Glenn, Ke Lin, Hai Juan Chen, Mirko Zuzel & John C. Cawley. (2004) The role of matrix metalloproteinase  9 in the pathogenesis of chronic lymphocytic leukaemia. British Journal of Haematology 125:2, pages 128-140.
Crossref
Ulrich R Hengge, Gudrun Tossing, Vivian Kouri & Stefan Fruehauf???. (2004) Graduated Systemic Treatment of AIDS-Associated Kaposi Sarcoma. American Journal of Cancer 3:3, pages 133-149.
Crossref
R. Daniel Bonfil, Pamela Osenkowski, Rafael Fridman & Michael L. Cher. 2004. The Biology of Skeletal Metastases. The Biology of Skeletal Metastases 173 195 .
J. Oliver McIntyre & Lynn M. Matrisian. (2003) Molecular imaging of proteolytic activity in cancer. Journal of Cellular Biochemistry 90:6, pages 1087-1097.
Crossref
T. Hashimoto, G. Wen, M. T. Lawton, N. J. Boudreau, A. W. Bollen, G.-Y. Yang, N. M. Barbaro, R. T. Higashida, C. F. Dowd, V. V. Halbach, W. L. Young & G. A. Rosenberg. (2003) Abnormal Expression of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Brain Arteriovenous Malformations * Growth and Bleeding in BAVM: Another Role for MMPs. Stroke 34:4, pages 925-931.
Crossref
William W Spurbeck, Catherine YC Ng, Elio F Vanin & Andrew M Davidoff. (2003) Retroviral vector-producer cell-mediated in vivo gene transfer of TIMP-3 restricts angiogenesis and neuroblastoma growth in mice. Cancer Gene Therapy 10:3, pages 161-167.
Crossref
Kasper Almholt & Morten Johnsen. 2003. Molecular Staging of Cancer. Molecular Staging of Cancer 31 42 .
Frances C Nelson, Efren Delos Santos, Jeremy I Levin, James M Chen, Jerauld S Skotnicki, John F DiJoseph, Michele A Sharr, Amy Sung, Loran M Killar, Rebecca Cowling, Guixian Jin, Catherine E Roth & J.Donald Albright. (2002) Benzodiazepine inhibitors of the MMPs and TACE. Bioorganic & Medicinal Chemistry Letters 12:20, pages 2867-2870.
Crossref
Ulrich R Hengge, Thomas Ruzicka, Stephen K Tyring, Martin Stuschke, Michael Roggendorf, Robert A Schwartz & Siegfried Seeber. (2002) Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. The Lancet Infectious Diseases 2:5, pages 281-292.
Crossref
Lisa M. CoussensBarbara FingletonLynn M. Matrisian. (2002) Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations. Science 295:5564, pages 2387-2392.
Crossref
Constance E. Brinckerhoff & Lynn M. Matrisian. (2002) Matrix metalloproteinases: a tail of a frog that became a prince. Nature Reviews Molecular Cell Biology 3:3, pages 207-214.
Crossref
G. BERGERS & D. HANAHAN. (2002) Combining Antiangiogenic Agents with Metronomic Chemotherapy Enhances Efficacy against Late-stage Pancreatic Islet Carcinomas in Mice. Cold Spring Harbor Symposia on Quantitative Biology 67:0, pages 293-300.
Crossref
Neeracha Ruangpanit, John T. Price, Kenn Holmbeck, Henning Birkedal-Hansen, Volkmar Guenzler, Xinfan Huang, Danny Chan, John F. Bateman & Erik W. Thompson. (2002) MT1-MMP-Dependent and -Independent Regulation of Gelatinase A Activation in Long-Term, Ascorbate-Treated Fibroblast Cultures: Regulation by Fibrillar Collagen. Experimental Cell Research 272:2, pages 109-118.
Crossref
Mary Helen Barcellos-Hoff & Antone L. Brooks. (2001) Extracellular Signaling through the Microenvironment: A Hypothesis Relating Carcinogenesis, Bystander Effects, and Genomic Instability. Radiation Research 156:5, pages 618-627.
Crossref
Mark D. SternlichtZena Werb. (2001) How Matrix Metalloproteinases Regulate Cell Behavior. Annual Review of Cell and Developmental Biology 17:1, pages 463-516.
Crossref
Chieh Chang & Zena Werb. (2001) The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends in Cell Biology 11, pages S37-S43.
Crossref
Chieh Chang & Zena Werb. (2001) The many faces of metalloproteases: cell growth, invasion, angiogenesis and metastasis. Trends in Cell Biology 11:11, pages S37-S43.
Crossref
Lisa J McCawley & Lynn M Matrisian. (2001) Matrix metalloproteinases: they're not just for matrix anymore!. Current Opinion in Cell Biology 13:5, pages 534-540.
Crossref
Barbara Fingleton & Lynn M. Matrisian. (2001) Matrix metalloproteinases as targets for therapy in Kaposi sarcoma. Current Opinion in Oncology 13:5, pages 368-373.
Crossref
Barbara Fingleton, Tracy Vargo-Gogola, Howard C. Crawford & Lynn M. Matrisian. (2001) Matrilysin [MMP-7] Expression Selects for Cells with Reduced Sensitivity to Apoptosis. Neoplasia 3:6, pages 459-468.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.